235 related articles for article (PubMed ID: 14720450)
1. Fat, diabetes, and liver injury in chronic hepatitis C.
Ratziu V; Trabut JB; Poynard T
Curr Gastroenterol Rep; 2004 Feb; 6(1):22-9. PubMed ID: 14720450
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance, steatosis, and fibrosis in Egyptian patients with chronic Hepatitis C virus infection.
Ahmed AM; Hassan MS; Abd-Elsayed A; Hassan H; Hasanain AF; Helmy A
Saudi J Gastroenterol; 2011; 17(4):245-51. PubMed ID: 21727730
[TBL] [Abstract][Full Text] [Related]
3. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.
Saadoun D; Asselah T; Resche-Rigon M; Charlotte F; Bedossa P; Valla D; Piette JC; Marcellin P; Cacoub P
Hepatology; 2006 Jun; 43(6):1337-45. PubMed ID: 16729318
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.
Haga Y; Kanda T; Sasaki R; Nakamura M; Nakamoto S; Yokosuka O
World J Gastroenterol; 2015 Dec; 21(46):12989-95. PubMed ID: 26675364
[TBL] [Abstract][Full Text] [Related]
5. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.
Leandro G; Mangia A; Hui J; Fabris P; Rubbia-Brandt L; Colloredo G; Adinolfi LE; Asselah T; Jonsson JR; Smedile A; Terrault N; Pazienza V; Giordani MT; Giostra E; Sonzogni A; Ruggiero G; Marcellin P; Powell EE; George J; Negro F;
Gastroenterology; 2006 May; 130(6):1636-42. PubMed ID: 16697727
[TBL] [Abstract][Full Text] [Related]
6. Impact of obesity on treatment of chronic hepatitis C.
Charlton MR; Pockros PJ; Harrison SA
Hepatology; 2006 Jun; 43(6):1177-86. PubMed ID: 16729327
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
[TBL] [Abstract][Full Text] [Related]
8. Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review.
Dyal HK; Aguilar M; Bhuket T; Liu B; Holt EW; Torres S; Cheung R; Wong RJ
Dig Dis Sci; 2015 Sep; 60(9):2813-24. PubMed ID: 26138651
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus and glucose and lipid metabolism.
Alaei M; Negro F
Diabetes Metab; 2008 Dec; 34(6 Pt 2):692-700. PubMed ID: 19195632
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans.
Hu KQ; Currie SL; Shen H; Cheung RC; Ho SB; Bini EJ; McCracken JD; Morgan T; Bräu N; Schmidt WN; Jeffers L; Wright TL;
Dig Dis Sci; 2007 Feb; 52(2):570-8. PubMed ID: 17226072
[TBL] [Abstract][Full Text] [Related]
11. Hepatic steatosis and hepatitis C: Still unhappy bedfellows?
Hwang SJ; Lee SD
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():96-101. PubMed ID: 21199519
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of insulin resistance in chronic hepatitis C genotype 1 and 3 patients.
Péres DP; Cheinquer H; Wolf FH; Cheinquer N; Falavigna M; Péres LD
Ann Hepatol; 2013; 12(6):871-5. PubMed ID: 24114816
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
[TBL] [Abstract][Full Text] [Related]
14. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
[TBL] [Abstract][Full Text] [Related]
15. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C.
Castera L
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):125-34. PubMed ID: 16557184
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of patients with cryptogenic liver cirrhosis in Okinawa, Japan.
Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kobashigawa K; Kinjo F; Saito A
Hepatogastroenterology; 2003; 50(54):2005-8. PubMed ID: 14696453
[TBL] [Abstract][Full Text] [Related]
17. Chronic hepatitis B associated with hepatic steatosis, insulin resistance, necroinflammation and fibrosis.
Yilmaz B; Koklu S; Buyukbayram H; Yalçin K; Korkmaz U; Posul E; Can G; Kurt M
Afr Health Sci; 2015 Sep; 15(3):714-8. PubMed ID: 26957957
[TBL] [Abstract][Full Text] [Related]
18. Influence of steatosis on progression of fibrosis and virological response in chronic hepatitis C cases.
Rafi H; Kabbaj N; Salihoun M; Amrani L; Acharki M; Guedira M; Nya M; Amrani N
Arab J Gastroenterol; 2011 Sep; 12(3):136-8. PubMed ID: 22055591
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of the fibrosis scores in patients with chronic hepatitis C associated with liver fibrosis and metabolic syndrome.
Miyaaki H; Ichikawa T; Taura N; Miuma S; Shibata H; Isomoto H; Takeshima F; Nakao K
Intern Med; 2011; 50(11):1137-41. PubMed ID: 21628926
[TBL] [Abstract][Full Text] [Related]
20. The predictive value of steatosis in hepatitis C virus infection.
Adinolfi LE; Restivo L; Marrone A
Expert Rev Gastroenterol Hepatol; 2013 Mar; 7(3):205-13. PubMed ID: 23445230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
